A Randomized Trial of Targeted Hyponatremia Correction in Hospitalized Patients HIT study @NEJMEvidence (2026)
ついにきましたね。130未満の低Na血症の患者において標的補正介入は正常Na達成率を高めたものの、30日死亡・再入院の複合転帰を減少させなかった。
https://t.co/ovv8qLH4Px
Among more than 800 000 CKD-PC participants, discordance between cystatin C and creatinine eGFR values was associated with increased risk of death, cardiovascular events, and kidney failure. 🧵
#KidneyWK@ASNKidney
https://t.co/Q1al5TUlO2
Presented at #KidneyWk:
In the PISCES trial involving participants receiving hemodialysis, fish oil (n−3 fatty acids) was compared with corn-oil placebo. The rate of serious cardiovascular events was lower with daily fish-oil supplementation. Full trial results: https://t.co/WUJwCWs4uV
Editorial: Fish Oil for Patients Receiving Hemodialysis — Red Herring or Great Catch? https://t.co/mxsRJZm2ei
@ASNKidney